Supplements

Conquering the Cancer Care Continuum™

Posted: January 1, 2012

RxProfiler™: ADCETRIS™ (brentuximab vedotin) for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Posted: October 25, 2011

Risk Management: A New Era of Patient Safety

Posted: June 2, 2010

Journal of Oncology Navigation & Survivorship

Posted: June 2, 2010